X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

SPT Labtech integrates recent acquisitions into unified brand and portfolio

Content Team by Content Team
13th October 2021
in News
SPT Labtech integrates recent acquisitions into unified brand and portfolio

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

SPT Labtech, a global leader in the design and development of automated instrumentation and consumables for life science applications, has unveiled new branding that brings together its technologies with those from recent acquisitions into a single entity. The merged portfolio and positioning reflect SPT Labtech’s commitment to harnessing the ingenuity and product development track record of its extended business to help scientists do better research.

The unified brand builds on the company’s 2021 strategic acquisitions of Apricot Designs (“apricot”), a liquid handling instrumentation provider, and BioMicroLab, a specialist in benchtop automation. The milestone also follows the recent appointment of a reinforced leadership team for SPT Labtech, tasked with overseeing and consolidating the entire business’s commercial, sales and product development operations to further the company’s ambitious growth plans.

Under the combined portfolio, the acquired businesses’ technologies will fall under the SPT Labtech brand as dedicated apricot and BioMicroLab product lines. All customers will benefit from the industry-leading support services delivered by SPT Labtech’s team of dedicated field service engineers and field application scientists.

David Newble, CEO, SPT Labtech said, “Our goal is to deliver end-to-end solutions that streamline laboratory workflows. With that in mind, it’s an important step for us to now formally integrate the apricot and BioMicroLab organisations into the SPT Labtech brand, enabling customers to benefit from a more seamless experience and interface with the entire portfolio. Our newly refreshed website, incorporating all ranges, will act as an important touchpoint for customers.”

Joby Jenkins, VP Business Development, SPT Labtech added, “This move reflects how seamlessly our acquired businesses and their talented teams have integrated within the SPT Labtech family. We increasingly benefit from cross-fertilizing ideas and technologies across our expanded portfolio to create novel products that solve customers’ critical workflow challenges. As a result, we anticipate bringing some exciting and genuinely disruptive new products to market in the near and longer term.”

About SPT Labtech
SPT Labtech makes products that transform the way scientists work. For nearly two decades, our expert scientists, engineers and business innovators have created innovative solutions for liquid handling, sample preparation and management that help accelerate research and make a real difference to human health. We work collaboratively with our customers, building trusted relationships that enable us to deliver exceptional, personalized experiences designed for real world challenges in the lab.

Previous Post

New Range of Refrigerators Provide Enhanced Functionality for Secure Blood Storage

Next Post

NanoImaging Services Collaborates with Viva Biotech to Offer an Integrated CryoEM Gene-to-Structure Workflow to Streamline Target Discovery

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
NanoImaging Services Collaborates with Viva Biotech to Offer an Integrated CryoEM Gene-to-Structure Workflow to Streamline Target Discovery

NanoImaging Services Collaborates with Viva Biotech to Offer an Integrated CryoEM Gene-to-Structure Workflow to Streamline Target Discovery

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In